A Phase 2 Trial of Gusacitinib in Systemic Lupus Erythematosus
Unknown Phase 1 NCT06238531
Study Description
A Clinical Trial to Test the Safety of an Investigational Drug (Gusacitinib) in Patients with Lupus
Study Details
- Registry ID:
- NCT06238531
- Conditions:
- Systemic Lupus Erythematosus
- Phase:
- Phase 1
- Start Date:
- Age Range:
- 18–99 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.